SMN2 and muscular atrophy: Current evidence suggests that nutritional metabolic dysregulation and muscular atrophy predominantly represent direct consequences of SMN protein insufficiency, whereas specific environmental exposures such as certain chemical compounds and epigenetic modifications may affect disease progression as independent regulatory pathways.